The most common ERBB2 mutations were the KD mutations at 2.3% (802 out of 34 368), followed by extracellular domain mutations (1.0%, 340 out of 34 368), which were identified in multiple subtypes of lung cancer. Here, ERBB2 is linked to lung carcinoma.